Abstract 450: The Role of CD38 as a Therapeutic Target for Protection Against Doxorubicin-induced Cardiotoxicity Through Nad+ Boosting

Authors: Thais R Peclat, Guillermo Agorrody, Lilian S Gomez, Eduardo N Chini

Published: 2020-10-27

DOI: 10.1161/res.127.suppl_1.450

Source: Full article

---

Abstract

Background: